Brett Goldberg
About Brett Goldberg
Brett Goldberg serves as the Lead of US ALS HCP Marketing at Amylyx Pharmaceuticals, bringing extensive experience in marketing and product management within the pharmaceutical industry. His background includes roles at Oncopeptides AB, Verastem Oncology, and Takeda Oncology, along with an MBA from Northeastern University.
Current Role at Amylyx Pharmaceuticals
Brett Goldberg serves as the Lead for US ALS HCP Marketing at Amylyx Pharmaceuticals. He has held this position since 2021 and is based in Cambridge, Massachusetts. In this role, he focuses on marketing strategies aimed at healthcare professionals involved in amyotrophic lateral sclerosis (ALS) treatment. His responsibilities include overseeing promotional materials and ensuring effective communication with the healthcare community.
Previous Experience in Oncology Marketing
Prior to his current role, Brett Goldberg worked at Oncopeptides AB as Associate Director of Marketing from 2020 to 2021. He also held the position of Senior Product Manager at Verastem Oncology from 2017 to 2020. His experience in oncology marketing includes launching products for hematologic malignancies and solid tumor indications, contributing to his expertise in the field.
Educational Background
Brett Goldberg earned a Bachelor of Arts degree in Psychology and Economics from Boston College, where he studied from 2007 to 2011. He is currently pursuing a Master of Business Administration (MBA) at the D'Amore-McKim School of Business at Northeastern University, with an expected graduation in 2024. Additionally, he studied at UNSW for 11 months in 2009.
Skills and Expertise
Brett Goldberg possesses a strong background in competitive intelligence and sales operations. His skill set includes market research, analytics, and revenue forecasting. He has expertise in marketing strategies directed at healthcare professionals, patients, and nurses, which supports his work in the pharmaceutical industry.
Career Progression in the Pharmaceutical Industry
Brett Goldberg has a diverse career in the pharmaceutical sector, having worked in various roles that emphasize commercial analytics and strategic planning. He served as Senior Analyst at ARIAD Pharmaceuticals, Inc. from 2014 to 2017, and as Manager of Business Analytics at Takeda Oncology for 10 months in 2017. This progression has equipped him with a comprehensive understanding of the industry.